Phase 4 Hepatitis B Trial, Recruiting (NCT03933384)

Phase 4 Hepatitis B Trial, Recruiting NCT03933384 Sponsor: Taichung Veterans General Hospital Condition: Hepatitis B

Printed from Voxsanity (voxsanity.com.au) — NCT03933384 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Hepatitis B

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are older than 20 years of age
You have been diagnosed with chronic hepatitis B
Your doctor has recommended that you start antiviral treatment for hepatitis B

Who may not be able to join:

Your liver disease is at an advanced stage where the liver is no longer functioning well (confirm with trial site)
Your kidneys are in very poor condition, at the most severe stage of kidney disease
You have previously taken certain antiviral medications (called nucleoside or nucleotide analogues) for hepatitis B
You have been treated with interferon therapy for hepatitis B in the past six months
You have a known history of HIV or hepatitis C infection alongside your hepatitis B
You have another cancer or serious tumour that is not currently under control
You are currently pregnant or breastfeeding
You are unable or unwilling to follow the rules and schedule set out by this study

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.

Contact this trial

Principal Investigator: Teng-Yu Lee, MD, PhD, Taichung Veterans General Hospital

Phone: 886-4-23592525

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT03933384

Sponsor: Taichung Veterans General Hospital

Phase: Phase 4

Status: Recruiting

Condition: Hepatitis B

Trial contact: 886-4-23592525

More information: https://clinicaltrials.gov/study/NCT03933384

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are older than 20 years of age
You have been diagnosed with chronic hepatitis B
Your doctor has recommended that you start antiviral treatment for hepatitis B

Who may not be able to join:

Your liver disease is at an advanced stage where the liver is no longer functioning well (confirm with trial site)
Your kidneys are in very poor condition, at the most severe stage of kidney disease
You have previously taken certain antiviral medications (called nucleoside or nucleotide analogues) for hepatitis B
You have been treated with interferon therapy for hepatitis B in the past six months
You have a known history of HIV or hepatitis C infection alongside your hepatitis B
You have another cancer or serious tumour that is not currently under control
You are currently pregnant or breastfeeding
You are unable or unwilling to follow the rules and schedule set out by this study

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Phase 4

Sponsor

Taichung Veterans General Hospital

Registry

ClinicalTrials.gov

Start date

19 August 2019

Est. completion

31 December 2027

Where this trial is recruiting

🇹🇼 Taiwan

Primary endpoints

HBV viral suppression; Renal safety: Change of estimated glomerular filtration rate

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov